Suraksha Diagnostic Limited (BOM:544293)

India flag India · Delayed Price · Currency is INR
284.15
-0.85 (-0.30%)
At close: Feb 13, 2026
Market Cap14.85B -5.1%
Revenue (ttm)2.94B +21.2%
Net Income332.95M +7.6%
EPS6.25 +5.9%
Shares Outn/a
PE Ratio44.60
Forward PE32.66
Dividendn/a
Ex-Dividend Daten/a
Volume401
Average Volume1,486
Open285.00
Previous Close285.00
Day's Range276.90 - 286.90
52-Week Range233.15 - 353.65
Betan/a
RSI57.61
Earnings DateFeb 5, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al... [Read more]

Industry Medical Laboratories
Founded 1992
Employees 1,300
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544293
Full Company Profile

Financial Performance

In fiscal year 2025, Suraksha Diagnostic's revenue was 2.52 billion, an increase of 15.26% compared to the previous year's 2.19 billion. Earnings were 318.24 million, an increase of 34.70%.

Financial Statements